The largest database of trusted experimental protocols

Etomoxir

Etomoxir is a potent and selective inhibitor of carnitine palmitoyltrasnferase 1 (CPT1), an enzyme crucial for fatty acid oxidation.
It has been widely studied for its potential therapeutic applications in metabolic disorders, cardiovascular disease, and cancer.
Etomoxir can modulate energy metabolism by blocking the transport of long-chain fatty acids into mitochondria, thereby shifting cellular fuel utilization from lipids to carbohydrates.
This metabolic reprogramming has been explored for its ability to improve insulin sensitivity, reduce lipid accumulation, and potentially inhibit tumor growth.
Reserach on Etomoxir's mechanims of action and its clinical utility is an active area of investigation.

Most cited protocols related to «Etomoxir»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2011
Antimycin A carbonyl cyanide phenylhydrazone etomoxir Glucose Glutamine Ionomycin NADH Oligomycins Oxygen Consumption Pyruvate Rotenone Seahorses Sodium

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
Adult Bone Morphogenetic Protein 4 Brain carnitine palmitoyltransferase 1A, human Cell Extracts Dietary Supplements Electroporation Embryo Epidermal growth factor etomoxir Fibroblast Growth Factor Gas Chromatography-Mass Spectrometry Heparin Injections, Intraperitoneal isolation Liquid Chromatography Malonyl Coenzyme A Mass Spectrometry Mus neuro-oncological ventral antigen 2, human Palmitic Acid Plasmids Proteins Psychological Inhibition Radioactivity Recombination, Genetic Short Hairpin RNA Strains Tamoxifen Tandem Mass Spectrometry Tissues Uterus Virus
OCR and ECAR values were determined using the XF24 Extracellular Flux Analyzer (Seahorse Bioscience) following the manufacturers’ protocols. For β-oxidation, WT MEFs and shRNA-mitoN MEFs (60,000 per well; 1 µg ml−1 Dox) were seeded overnight in a XF24 cell-culture microplate at 37 °C under 5% CO2 (Seahorse Bioscience). Following 1 hr equilibration with 1X KHB buffer (111 mM NaCl, 4.7 mM KCl, 2 mM MgSO4, 1.2 mM Na2HPO4) supplemented with 0.5 mM carnitine and 2.5 mM glucose, cells were subjected to treatment of a palmitate-BSA-conjugate (200 µM; C:16:0), followed by etomoxir (100 µM). OCR measurements were recorded at set interval time-points. For electron-flow (EF) measurements, isolated mitochondria were pelleted in a XF24 cell-culture microplate by centrifugation (2,000 g for 20 min at 4 °C) in 1X MAS buffer (70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EDTA in 0.2% FA-free BSA) supplemented with 10 mM pyruvate, 10 mM malate and 4 µM FCCP. OCR and ECAR measurements were obtained following sequential additions of rotenone (2 µM final concentration), succinate (10 mM), antimycin A (4 µM) and ascorbate (10 mM) (the latter containing 1 mM TMPD). For ECAR glycolytic flux experiments using whole-tissue slices, oligomycin (2 µM), FCCP (4 µM), 2-DG (100 mM) and antimycin A (10 µM) were added to tissues in an XF24 islet-capture Microplate (Seahorse Bioscience). All compounds and materials above were obtained from Sigma-Aldrich. For mitochondrial oxidative-stress, the protein-carbonylation assay was performed as previously described37 (link). For lipid-peroxidation, bound 8-isoPGF2α levels were determined as previously detailed19 (link). The mitochondrial membrane potential (ΔΨm) experiments are detailed in the Supplementary Methods.
Publication 2012
Antimycin A Biological Assay Buffers Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone Carnitine Cell Culture Techniques Cells Centrifugation Edetic Acid Electrons etomoxir Glucose Glycolysis HEPES Lipid Peroxidation Magnesium Chloride malate Mannitol Membrane Potential, Mitochondrial Mitochondria Oligomycins Oxidative Stress Palmitate Protein Carbonylation Pyruvate Rotenone Seahorses Short Hairpin RNA Sodium Chloride Succinate Sucrose Sulfate, Magnesium Tissues

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Acetylcysteine agonists Amber Biological Assay Biopharmaceuticals Caimans Cells CFC1 protein, human Common Cold Culture Media etomoxir Growth Factor GW 501516 Intestines isononanoyl oxybenzene sulfonate KD3010 Lipids matrigel noggin protein Organoids Palmitic Acid Paneth Cells Proteins Stem Cells Tamoxifen villin Y 27632

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Antimycin A Biological Assay Carnitine O-Palmitoyltransferase CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes Cell Respiration Cells Centrifugation Clostridium perfringens theta-toxin Cyanides etomoxir etomoxiryl-coenzyme A Exercise Tests Fatty Acids Glucose Glutamate Glutamine HEPES IL2RA protein, human Interleukin-15 Levocarnitine Lysine malate Mitochondria Mitomycin Molar Nodes, Lymph Oligomycins Palmitate Palmitoyl Coenzyme A phenylhydrazone Plasma Plasma Membrane Poly A Pyruvate Respiratory Rate Rotenone Seahorses Sodium Sodium Chloride Spleen Succinate Sulfate, Magnesium T-Lymphocyte

Most recents protocols related to «Etomoxir»

Splenic lymphoma cells from plck-GAPDH mice were injected intravenously into recipient NSG mice. Fourteen days after tumor cell injection, lymphoma engrafted NSG mice were treated by IP injection with etomoxir (20 mg/kg, Sigma-Aldrich), an inhibitor of fatty acid oxidation or with vehicle (100 μl PBS/mouse). The treatment regimen consisted in 3 injections per week.
Full text: Click here
Publication 2024
The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured in LCA-treated cells using a Seahorse XF96 analyzer (Agilent Technologies, Santa Clara, CA, USA). Cells were allowed to attach overnight after seeding in 96-well Seahorse assay plates (5000 cells/well). After treating with vehicle (DMSO) or LCA for 48 h, cells were incubated in pre-warmed XF assay media for 1 h at 37 °C in a non-CO2 incubator. Baseline OCR was recorded 5 times for 5 min. Then, cells were treated sequentially with etomoxir (50 μM), oligomycin (10 μM), and antimycin (10 μM). Each OCR was recorded 5 times for 5 min. All measurements were normalized to protein levels using the SRB assay. LCA treatment was represented in 6-8 wells per experiment and replicate experiments were performed three times. Fold change values were calculated.
Basal respiration was defined as the baseline respiration minus the antimycin-resistant respiration. Etomoxir-resistant OCR (etomoxir−antimycin) was defined as the oxygen consumption related to glucose and amino acid oxidation. Fatty acid oxidation was defined as etomoxir-sensitive OCR (baseline−etomoxir). Uncoupled respiration was defined as oligomycin-resistant respiration (oligomycin−antimycin), and ATP-linked respiration was defined as oligomycin-sensitive OCR (baseline−oligomycin).
Full text: Click here
Publication 2024
Female SCID mice or C57/BL6 micec (6-8 weeks old) were obtained from the Model Animal Research Center of Nanjing University and housed under pathogen-free conditions on a 12/12 h light/dark cycle with free access to food and water. For the MDA-MB-231 metastasis model 1.5×10 6 MDA-MB-231 cells suspended in 100μL PBS were injected into SCID mice through the tail vein.
Vehicle or 40mg/kg etomoxir was injected intraperitoneally every 2 days and mice were weighed every week before sacrificed. At the endpoint, respective metastatic organs were harvested and metastasis was confirmed by H&E staining. For the E0771 metastasis model, 5×10 5 E0771 vector or NNMToverexpression cells suspended in 100μL PBS were injected into C57/BL6 mice through the tail vein.
Cells were treated with etomoxir 2 days before injection, and vehicle or 40mg/kg etomoxir were injected intraperitoneally every 2 days. The lungs were harvested for H&E staining and IHC after 2 weeks. For the MCF-7 metatstasis assay in vivo, MCF-7 vector and NNMT-OE cells were labeled with CellTracker Green (C2925, ThermoFisher) and injected into SCID mice via the tail vein. For the etomoxir treatment group, cells were treated with etomoxir 2 days before injection. Lung tissues were collected at 4 hours and 24 hours after injection and then processed into frozen sections, which were stained with DAPI for fluorescence microscopy.
Publication 2024
Not available on PMC !
Before the experiment, solidified culture medium containing 0.7% agarose was poured into six-well plate. 4-6×10 4 breast cancer cells and reagent (lipid mixture or etomoxir) were mixed with culture medium containing 0.35% agarose before being added to the solidified culture medium. After solidification, 1mL culture medium with lipid mixture or etomoxir was added to the top layer. The culture medium containing the reagent was changed every 2-3 days. After 2-3 weeks, images were taken with a Carl Zeiss Microscope.
Publication 2024
ALI model of mice was induced as previously described43 (link) via LPS (E. coli O111:B4; 5 mg/kg; Sigma-Aldrich, St. Louis, MO, USA) intratracheal injection (i.t.). Twelve hours after LPS treatment, the mice were sacrificed for further detection. To explore the role of CPT1A in ALI mice, mice were randomly divided into 4 groups: control, ALI, AAV-CPT1A, and ALI + AAV-CPT1A groups. Overexpression of CPT1A was administered by 1.5 × 1012 genome copies (gc)/kg of AAV9 via tail-vein injection. The mice in the control group were treated with saline and the control AAV9. The ALI mice were treated with LPS and the control AAV9. To explore the role of CPT1A blocking on ALI mice, mice were randomly divided into 3 groups: control, ALI, and ALI + etomoxir groups. Mice in the ALI + etomoxir group received etomoxir (20 mg/kg; MedChemExpress, USA) via intraperitoneal injection 1 h before saline or LPS administration. For the survival study, mice were treated with LPS at a lethal dose (25 mg/kg, i.t.). Mice in the control group received saline only. The survival rate was monitored every 6 h.
Full text: Click here
Publication 2024

Top products related to «Etomoxir»

Sourced in United States, Germany, France
Etomoxir is a laboratory reagent used in research applications. It functions as an inhibitor of carnitine palmitoyltransferase 1 (CPT1), a key enzyme involved in the mitochondrial beta-oxidation of fatty acids. Etomoxir is utilized by researchers to study metabolic processes and pathways related to lipid metabolism.
Sourced in United States, Germany, United Kingdom, Italy, Sao Tome and Principe, Japan, Macao, France, China, Belgium, Canada, Austria
Oligomycin is a laboratory product manufactured by Merck Group. It functions as an inhibitor of the mitochondrial F1F0-ATP synthase enzyme complex, which is responsible for the synthesis of adenosine triphosphate (ATP) in cells. Oligomycin is commonly used in research applications to study cellular bioenergetics and mitochondrial function.
Sourced in United States, Germany
Etomoxir is a small molecule compound that functions as an inhibitor of carnitine palmitoyltransferase 1 (CPT1), an enzyme involved in the transportation of fatty acids into the mitochondria for β-oxidation. It is used as a research tool to study the role of fatty acid oxidation in various biological processes.
Sourced in United States, Germany, Italy, United Kingdom, Sao Tome and Principe, China, Macao, Spain, India, Japan, France, Belgium, Israel, Canada
Rotenone is a naturally occurring insecticide and piscicide derived from the roots of certain tropical plants. It is commonly used as a research tool in laboratory settings to study cellular processes and mitochondrial function. Rotenone acts by inhibiting the electron transport chain in mitochondria, leading to the disruption of cellular respiration and energy production.
Sourced in United States, Germany, Italy, United Kingdom, Sao Tome and Principe, China, Japan, Macao, France, Belgium
Antimycin A is a chemical compound that acts as a potent inhibitor of mitochondrial respiration. It functions by blocking the electron transport chain, specifically by interfering with the activity of the cytochrome bc1 complex. This disruption in the respiratory process leads to the inhibition of cellular respiration and energy production within cells.
Sourced in United States, China
Etomoxir is a chemical compound used in laboratory settings. It functions as an inhibitor of carnitine palmitoyltransferase 1 (CPT1), an enzyme involved in the oxidation of fatty acids. Etomoxir is commonly utilized in research studies to investigate metabolic processes and pathways related to energy production and lipid metabolism.
Sourced in United States, Germany, United Kingdom
UK5099 is a laboratory equipment product manufactured by Merck Group. It serves as a core functional component for various scientific applications. The device specifications and capabilities are maintained in a factual and unbiased manner, without any interpretations or extrapolations on its intended use.
Sourced in United States
The XF96 Extracellular Flux Analyzer is a laboratory instrument designed to measure the metabolic activity of cells in a high-throughput manner. The device is capable of simultaneously assessing the oxygen consumption rate and extracellular acidification rate of cells, providing insights into their respiratory and glycolytic activity.
Sourced in United States, Germany, United Kingdom, Japan, Italy, Sao Tome and Principe, Israel
FCCP is a chemical compound used in laboratory research. It functions as an uncoupler of oxidative phosphorylation, disrupting the proton gradient across the mitochondrial inner membrane. This action has applications in studies of mitochondrial function and energy metabolism.
Sourced in United States
Etomoxir is a synthetic compound that functions as an irreversible inhibitor of carnitine palmitoyltransferase 1 (CPT1), an enzyme critical for the transport of long-chain fatty acids into the mitochondria for beta-oxidation. It is commonly used in research applications to study cellular energy metabolism and fatty acid oxidation.

More about "Etomoxir"

Etomoxir is a potent and selective inhibitor of carnitine palmitoyltransferase 1 (CPT1), a critical enzyme involved in fatty acid oxidation.
This metabolic modulator has been extensively studied for its potential therapeutic applications in various conditions, including metabolic disorders, cardiovascular disease, and cancer.
Etomoxir's mechanism of action involves blocking the transport of long-chain fatty acids into mitochondria, shifting cellular fuel utilization from lipids to carbohydrates.
This metabolic reprogramming has been explored for its ability to improve insulin sensitivity, reduce lipid accumulation, and potentially inhibit tumor growth.
Other related compounds like Oligomycin, Rotenone, Antimycin A, and UK5099 are also inhibitors of cellular energy metabolism, each targeting different aspects of mitochondrial function.
The XF96 Extracellular Flux Analyzer is a widely used tool for assessing cellular respiration and the effects of these metabolic modulators.
FCCP (carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) is a protonophore that can uncouple mitochondrial oxidative phosphorylation, leading to increased oxygen consumption and energy expenditure.
Researchers often utilize FCCP in combination with other inhibitors like Etomoxir to study the complexities of cellular energy metabolism.
The ongoing research on Etomoxir's mechanisms of action and its potential clinical utility is an active and exciting area of investigation, with implications for the management of various metabolic and disease states.
By leveraging the insights from the available literature and the capabilities of AI-driven tools like PubCompare.ai, researchers can optimize their Etomoxir studies and unlock new discoveries.